AlgoRx Acquires Rights to Novel Antimigraine Therapy; Clinical Trials to Commence in 2003.Business Editors/Health/Medical Writers CRANBURY, N.J.--(BUSINESS WIRE)--Feb. 11, 2003 AlgoRx Pharmaceuticals, Inc., a specialty pharmaceutical company with significant expertise in the development of pain therapeutics, announced today it had acquired rights to its third clinical-stage pipeline product, ALGRX 2872. ALGRX 2872 will be evaluated for treatment of migraine headaches Migraine Headache Definition Migraine is a type of headache marked by severe head pain lasting several hours or more. Description Migraine is an intense and often debilitating type of headache. , a U.S. prescription market of approximately $2.1 billion. ALGRX 2872 was inlicensed from a physician investigator. ALGRX 2872 consists of a triptan antimigraine drug in a novel formulation. To date, more than 150 patients have been treated, and the drug has been found to be efficacious ef·fi·ca·cious adj. Producing or capable of producing a desired effect. See Synonyms at effective. [From Latin effic and well-tolerated. Additional clinical trials will take place in 2003, with the goal of the clinical plan to demonstrate efficacy comparable to injected triptans and better tolerability tol·er·a·ble adj. 1. Capable of being tolerated; endurable. 2. Fairly good; passable. See Synonyms at average. tol . "We are pleased to add ALGRX 2872, a potentially important product in the treatment of migraine migraine (mī`grān), headache characterized by recurrent attacks of severe pain, usually on one side of the head. It may be preceded by flashes or spots before the eyes or a ringing in the ears, and accompanied by double vision, nausea, , to our pipeline," said Dr. Ronald M. Burch, AlgoRx' President and Chief Executive Officer. "In fewer than two years we have successfully acquired three clinical stage pain products and look forward to rapidly moving these products through to commercialization." Roughly 28 million Americans suffer more than 600 million migraine attacks each year; this is equal to one migraine sufferer in every four U.S. households, according to according to prep. 1. As stated or indicated by; on the authority of: according to historians. 2. In keeping with: according to instructions. 3. data released by the National Headache Foundation. Currently available treatments include adrenergic antagonists An Adrenergic antagonist is a pharmaceutical substance that acts to inhibit the action of the adrenergic receptors. It has the opposite effect as adrenergic agonists. , NSAIDS, triptans, and OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). headache remedies. AlgoRx Pharmaceuticals, headquartered in Cranbury N.J., is a specialty pharmaceutical company focused on successfully bringing pain management products to market in areas of unmet need. AlgoRx has assembled an expert team with substantial experience in the pain sector to identify, acquire and rapidly develop its products. AlgoRx's late stage pipeline consists of both conventional drug candidates and novel formulations of existing drugs. ALGRX 3268 and ALGRX 4975 are in clinical trials. AlgoRx, a private venture stage company, was formed in April 2001, and has raised $34 million to date. For additional information, please see www.algorx.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion